[Erythropoietin and intravenous iron to save blood in surgery]. / Strategien zur Bluteinsparung in der Chirurgie: Der Stellenwert von Erythropoetin und der parenteralen Eisensubstitution.
Praxis (Bern 1994)
; 93(46): 1905-10, 2004 Nov 10.
Article
in De
| MEDLINE
| ID: mdl-15580882
ABSTRACT
Recombinant human erythropoietin (rHuEPO) and intravenous (i.v.) iron administration may be useful tools to save blood in surgery. In the perioperative period, rHuEPO should be used in slightly anemic patients for whom an autologous predonation program is not recommended (or feasible). In such cases, i.v. iron is only given if there is a functional or real iron deficiency state. In the post-operative period, i.v. iron is administered in association with rHuEPO in an attempt to rapidly correct severe post-operative anemia. The same regimen is used for patients undergoing surgery for inflammatory bowel disease and rheumatoid arthritis. Finally, other particular categories of patients, such as those with reduced body weight (< 50 kg), candidates for surgery with increased blood needs (> 5 units), or those with a too-short period of time before surgery, also benefit from the administration of these two drugs.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Surgical Procedures, Operative
/
Erythropoietin
/
Iron
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Humans
Language:
De
Journal:
Praxis (Bern 1994)
Year:
2004
Document type:
Article